TELO NASDAQ
Telomir Pharmaceuticals, Inc. Common Stock
1W: -4.1%
1M: +5.4%
3M: -7.1%
YTD: -11.9%
1Y: -15.1%
$1.18
+0.01 (+0.85%)
Weekly Expected Move ±6.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2024-02-13
Earliest Filing
2025-10-20
Latest Filing
acquirer: 2
target: 2
partner: 1
Counterparties (Filed by TELO)
5 relationshipsCompanies named in TELO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. | TELO | acquirer | Acquiring TELI Pharmaceuticals, Inc. via a stock exchange transaction. | 2025-10-20 | View |
| TELI Pharmaceuticals, Inc. | — | target | Target company being acquired by Telomir Pharmaceuticals, Inc. | 2025-10-20 | View |
| Telomir Pharmaceuticals, Inc. | TELO | target | Company issuing common stock in an underwriting agreement | 2024-02-13 | View |
| Kingswood Investments | — | acquirer | Representative of the several underwriters purchasing shares | 2024-02-13 | View |
| Kingswood Capital Partners, LLC | — | partner | Parent entity of Kingswood Investments acting as representative of underwriters | 2024-02-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-17 | Regulation FD; Exhibits | View | |
| 2026-09-16 | Shareholder Vote; Exhibits | View | |
| 2026-09-14 | Regulation FD; Exhibits | View | |
| 2026-08-10 | Regulation FD; Exhibits | View | |
| 2026-06-15 | Regulation FD; Exhibits | View | |
| 2026-06-08 | Officer/Director Change; Exhibits | View | |
| 2026-05-20 | Regulation FD; Exhibits | View | |
| 2026-04-30 | Other Events | View | |
| 2026-04-24 | Material Agreement; Acquisition/Disposition; Unregistered Equity Sales; Exhibits | Agreement Acquisition | View |
| 2026-03-31 | Other Events | View | |
| 2026-03-31 | Other Events | View | |
| 2026-03-27 | Officer/Director Change; Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-02-17 | Other Events | View | |
| 2026-02-05 | Other Events | View | |
| 2026-01-12 | Notice of Delisting or Transfer | View | |
| 2026-01-05 | Other Events | View | |
| 2025-12-22 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-17 | Other Events | View | |
| 2025-11-24 | Other Events | View | |
| 2025-11-20 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR